Frequent alteration of p63 expression in human primary bladder carcinomas.

Abstract:

:p63, a recently identified member of the p53 gene family, encodes multiple products with transactivating, death-inducing, and dominant-negative activities. To explore the penetrance of p63 in bladder carcinogenesis, we performed expression and mutation analyses of two major isotypes, TAp63 and deltaNp63, in 63 bladder specimens. In 12 normal tissues, TAp63 was expressed at an easily detectable level whereas deltaNp63 was absent or extremely low. While none of 47 carcinomas showed allelic deletion of the gene, marked reduction of TAp63 and abnormal overexpression of deltaNp63 were found in 25 (53.2%) and 30 (63.8%) carcinomas, respectively. Tumor-specific alteration of TAp63 and deltaNp63 expression was identified in two and three of six matched sets, respectively. In addition, reduced expression of TAp63 showed a correlation with tumor stage and grade. Abnormal expression of TAp63 or deltaNp63 isoform was also observed in three of four cell lines, and treatment with 5-Aza-2'-deoxycytidine led to up- or down-regulation of TAp63 and/or deltaNp63 expression, suggesting that the promoters of both isoforms might be affected by DNA methylation, but not in a reciprocal fashion. No sequence alteration of p63 was identified in 47 carcinomas whereas 17 (34.8%) of these showed p53 mutations, and no association between p63 expression and the mutational status of p53 or expression of p21Waf1, MDM2, and 14-3-3sigma was recognized. Our data suggest that altered expression of p63 is a frequent event in bladder carcinogenesis and might contribute to the progression of bladder tumors, possibly via the mechanism(s) distinct from the p53 pathway.

journal_name

Cancer Res

journal_title

Cancer research

authors

Park BJ,Lee SJ,Kim JI,Lee SJ,Lee CH,Chang SG,Park JH,Chi SG

subject

Has Abstract

pub_date

2000-07-01 00:00:00

pages

3370-4

issue

13

eissn

0008-5472

issn

1538-7445

journal_volume

60

pub_type

杂志文章
  • Estrogen-induced potentiation of DNA damage and cytotoxicity in human breast cancer cells treated with topoisomerase II-interactive antitumor drugs.

    abstract::Hormone stimulation of responsive neoplasms is a potential strategy for improving the target selectivity of cancer chemotherapy. Using an alkaline DNA-unwinding technique to detect drug-induced DNA strand breakage, we have shown that estrogen stimulation of T-47D human breast cancer cells enhances induction of DNA cle...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Epstein RJ,Smith PJ

    更新日期:1988-01-15 00:00:00

  • Experimental antitumor activity against murine tumor model systems of 8-carbamoyl-3-(2-chloroethyl)imidazo[5,1-d]-1,2,3,5-tetrazin-4(3 H)-one (mitozolomide), a novel broad-spectrum agent.

    abstract::8-Carbamoyl-3-(2-chloroethyl)imidazo[5,1-d]-1,2,3,5-tetrazin-4(3H) -one (mitozolomide) demonstrates curative action against a range of murine tumor model systems. At single doses of between 20 and 40 mg/kg, the latter of which approximates the 10% lethal dose value in mice, the compound elicited cures against the L121...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Hickman JA,Stevens MF,Gibson NW,Langdon SP,Fizames C,Lavelle F,Atassi G,Lunt E,Tilson RM

    更新日期:1985-07-01 00:00:00

  • Genetic vaccination with "self" tyrosinase-related protein 2 causes melanoma eradication but not vitiligo.

    abstract::"Self" melanocyte differentiation antigens are potential targets for specific melanoma immunotherapy. Vaccination against murine tyrosinase-related protein (TRP)-1/gp75 was shown recently to cause melanoma rejection, which was accompanied by autoimmune skin depigmentation (vitiligo). To further explore the linkage bet...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Bronte V,Apolloni E,Ronca R,Zamboni P,Overwijk WW,Surman DR,Restifo NP,Zanovello P

    更新日期:2000-01-15 00:00:00

  • Quantitative measurements of the changes in protein thiols in cervical intraepithelial neoplasia and in carcinoma of the human uterine cervix provide evidence for the existence of a biochemical field effect.

    abstract::Quantitative micromethods have been used for measuring reactive protein thiols (PSHr), total reactive protein sulfur (TRPS), total protein thiols (PSHt), and protein disulfides (PDS) in fixed frozen sections of human uterine cervix. PSHr and TRPS were stained using 2,2'-dihydroxy-6,6'-dinaphthyl disulfide; PSHt and PD...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Benedetto C,Bajardi F,Ghiringhello B,Marozio L,Nöhammer G,Phitakpraiwan P,Rojanapo W,Schauenstein E,Slater TF

    更新日期:1990-10-15 00:00:00

  • Hyperthermia enables tumor-specific nanoparticle delivery: effect of particle size.

    abstract::The efficacy of novel cancer therapeutics has been hampered by the ability to deliver these agents to the tumor at effective concentrations. Liposomes have been used as a method to overcome some delivery issues and, in combination with hyperthermia, have been shown to increase drug delivery to tumors. Particle size ha...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Kong G,Braun RD,Dewhirst MW

    更新日期:2000-08-15 00:00:00

  • Detection of mutant-specific responses by macrophage migration inhibition reactions induced by wild-type and mutant polyoma viruses and polyoma virus-infected cells.

    abstract::Macrophage migration inhibition responses of mice immunized with mutant polyoma viruses or with cells transformed and/or infected by them have been studied. The macrophage migration inhibition reaction revealed individual differences. In several cases, mice immunized with a mutant virus responded preferentially or exc...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Szigeti R,Dalianis T,Ramqvist T,Ito Y,Klein G

    更新日期:1984-03-01 00:00:00

  • ATR pathway inhibition is synthetically lethal in cancer cells with ERCC1 deficiency.

    abstract::The DNA damage response kinase ATR and its effector kinase CHEK1 are required for cancer cells to survive oncogene-induced replication stress. ATR inhibitors exhibit synthetic lethal interactions, with deficiencies in the DNA damage response enzymes ATM and XRCC1 and with overexpression of the cell cycle kinase cyclin...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-13-3229

    authors: Mohni KN,Kavanaugh GM,Cortez D

    更新日期:2014-05-15 00:00:00

  • Immunoassay of serum galactosyltransferase isoenzyme II in cancer patients and control subjects.

    abstract::Serum galactosyltransferase isoenzyme II (GT-II) was assayed in 409 coded serum samples obtained from the National Cancer Institute Tumor Serum Bank using a monoclonal antibody-based immunoassay. The serum panel consisted of samples from patients with confirmed, metastatic ovarian, breast, stomach, esophageal, pancrea...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Uemura M,Winant RC,Brandt AE

    更新日期:1988-09-15 00:00:00

  • Lymphatic obstruction in carcinomatous ascites.

    abstract::The i.p. inoculation of C3H mice with 5 times 10-6 cells of a transplantable ovarian carcinoma invariably evokes accumulation of large amounts of ascitic fluid. Histological and pharmacotherapeutic studies indicate that obstruction to peritoneal lymphatic drainage is a key factor in the formation of carcinomatous asci...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Feldman GB

    更新日期:1975-02-01 00:00:00

  • Acid pH in tumors and its potential for therapeutic exploitation.

    abstract::Measurement of pH in tissue has shown that the microenvironment in tumors is generally more acidic than in normal tissues. Major mechanisms which lead to tumor acidity probably include the production of lactic acid and hydrolysis of ATP in hypoxic regions of tumors. Further reduction in pH may be achieved in some tumo...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Tannock IF,Rotin D

    更新日期:1989-08-15 00:00:00

  • Tumor growth instability and its implications for chemotherapy.

    abstract::Optimal delivery of chemotherapy intensity is dependent on host- and tumor-specific characteristics. In this article, the chemotherapy late intensity schedule is revised to account for tumor growth instability, where a small tumor cell fraction emerges that exhibits a higher proliferation rate than the parent strain. ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-09-0653

    authors: Castorina P,Carcò D,Guiot C,Deisboeck TS

    更新日期:2009-11-01 00:00:00

  • Increased methotrexate resistance and dhfr gene amplification as a consequence of induced Ha-ras expression in NIH 3T3 cells.

    abstract::Oncogene activation and loss of tumor suppressor genes are known to play a role in tumor initiation as well as its progression. The potential roles of these genes in perturbation of genome stability has become a major interest. To better understand the relationship between expression of an oncogene and genetic instabi...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Wani MA,Xu X,Stambrook PJ

    更新日期:1994-05-01 00:00:00

  • Distinctive protein pattern in two-dimensional electrophoretograms of cancerous prostatic tissues.

    abstract::In this report, we describe methods used to analyze the protein composition of sectioned frozen prostatic tissues by two-dimensional gel electrophoresis. Our results show a high degree of homology in two-dimensional electrophoretograms of proteins extracted from frozen sections of malignant prostate glands. Such homol...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Guevara J Jr,Herbert BH,Raymond AK,Batsakis JG

    更新日期:1986-07-01 00:00:00

  • ATDC/TRIM29 phosphorylation by ATM/MAPKAP kinase 2 mediates radioresistance in pancreatic cancer cells.

    abstract::Pancreatic ductal adenocarcinoma (PDAC) is characterized by therapeutic resistance for which the basis is poorly understood. Here, we report that the DNA and p53-binding protein ATDC/TRIM29, which is highly expressed in PDAC, plays a critical role in DNA damage signaling and radioresistance in pancreatic cancer cells....

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-13-2289

    authors: Wang L,Yang H,Palmbos PL,Ney G,Detzler TA,Coleman D,Leflein J,Davis M,Zhang M,Tang W,Hicks JK,Helchowski CM,Prasad J,Lawrence TS,Xu L,Yu X,Canman CE,Ljungman M,Simeone DM

    更新日期:2014-03-15 00:00:00

  • Expression of membrane-type matrix metalloproteinase in human gastric carcinomas.

    abstract::We have examined the implications of membrane-type matrix metalloproteinase (MT-MMP) for activation of the zymogen of MMP-2 (proMMP-2) in human gastric carcinoma. Northern blot analysis demonstrated exclusive expression of MT-MMP in the carcinoma tissues. Immunohistochemically, MT-MMP was colocalized in the carcinoma ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Nomura H,Sato H,Seiki M,Mai M,Okada Y

    更新日期:1995-08-01 00:00:00

  • Inhibition by the dopamine antagonist haloperidol of experimental carcinogenesis induced by azoxymethane in rat colon.

    abstract::The effects of the dopamine agonist bromocriptine and antagonist haloperidol on the incidence and histology of colon tumors induced by azoxymethane and on the labeling index of colon mucosa were investigated in Wistar rats. Rats received weekly s.c. injections of 7.4 mg/kg of body weight azoxymethane for 10 weeks and ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Iishi H,Baba M,Tatsuta M,Okuda S,Taniguchi H

    更新日期:1991-11-15 00:00:00

  • Glutamine-Directed Migration of Cancer-Activated Fibroblasts Facilitates Epithelial Tumor Invasion.

    abstract::Tumors are complex tissues composed of transformed epithelial cells as well as cancer-activated fibroblasts (CAF) that facilitate epithelial tumor cell invasion. We show here that CAFs and other mesenchymal cells rely much more on glutamine than epithelial tumor cells; consequently, they are more sensitive to inhibiti...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-20-0622

    authors: Mestre-Farrera A,Bruch-Oms M,Peña R,Rodríguez-Morató J,Alba-Castellón L,Comerma L,Quintela-Fandino M,Duñach M,Baulida J,Pozo ÓJ,García de Herreros A

    更新日期:2021-01-15 00:00:00

  • Efficacy of the quinocarmycins KW2152 and DX-52-1 against human melanoma lines growing in culture kand in mice.

    abstract::Quinocarmycin monicitrate (KW2152) and its analogue, DX-52-1, demonstrated specificity for melanomas in the National Cancer Institute in vitro human tumor cell line drug screen. In contrast to most cell lines, a 50% reduction in tumor cell burden (as measured protein) at the end of a 48-h drug incubation was produced ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Plowman J,Dykes DJ,Narayanan VL,Abbott BJ,Saito H,Hirata T,Grever MR

    更新日期:1995-02-15 00:00:00

  • Antitumor Properties of an IgG2-Enhanced Next-Generation MET Monoclonal Antibody That Degrades Wild-Type and Mutant MET Receptors.

    abstract::A sound rationale exists for antibody targeting of the MET receptor tyrosine kinase, but therapeutic agents that can broadly block HGF ligand binding and exon 14-mutated or amplified MET to induce receptor degradation have yet to be reported. Here we report the identification of several MET monoclonal antibodies (mAb)...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-16-0026

    authors: Yang Y,Mandiyan S,Robinson BS,McMahon G

    更新日期:2016-10-01 00:00:00

  • Cytokinetic and cytotoxic effects of antimetabolites on 9L rat brain tumor cells in vitro.

    abstract::Treatment of exponentially growing 9L monolayer cells with graded concentrations of methotrexate or 5-fluorouracil (5-FUra) resulted in approximately 95% cell kill, corresponding to the percentage of cells in this system labeled by autoradiography (98%). Additional cell kill could be obtained if 5-FUra was administere...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Weizsaecker M,Hoshino T,Deen DF,Kobayashi S

    更新日期:1981-10-01 00:00:00

  • Tumor Cell-Derived IL1β Promotes Desmoplasia and Immune Suppression in Pancreatic Cancer.

    abstract::Pancreatic ductal adenocarcinoma (PDA) is an aggressive malignancy typified by a highly stromal and weakly immunogenic tumor microenvironment that promotes tumor evolution and contributes to therapeutic resistance. Here, we demonstrate that PDA tumor cell-derived proinflammatory cytokine IL1β is essential for the esta...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-19-2080

    authors: Das S,Shapiro B,Vucic EA,Vogt S,Bar-Sagi D

    更新日期:2020-03-01 00:00:00

  • Molecular basis for the critical role of suppressor of cytokine signaling-1 in melanoma brain metastasis.

    abstract::Our recent study found that activation of signal transducer and activator of transcription 3 (Stat3) is up-regulated in human brain metastatic cells and contributes to brain metastasis of melanoma. However, the molecular mechanisms underlying this increased Stat3 activation and effect on brain metastasis are unknown. ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-08-1429

    authors: Huang FJ,Steeg PS,Price JE,Chiu WT,Chou PC,Xie K,Sawaya R,Huang S

    更新日期:2008-12-01 00:00:00

  • A selective effect of methylglyoxal-bis(guanylhydrazone) on the synthesis of mitochondrial DNA of cultured L1210 leukemia cells.

    abstract::Methylglyoxal-bis(guanylhydrazone) (MGBG) is a polycationic drug which is useful in the chemotherapy of lymphoid and myeloid proliferative disorders. The drug has recently been shown to produce selective ultrastructural damage to the mitochondria of proliferating cell populations. It is important to understand the mol...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Feuerstein B,Porter CW,Dave C

    更新日期:1979-10-01 00:00:00

  • Loss of heterozygosity in human primary prostate carcinomas: a possible tumor suppressor gene at 7q31.1.

    abstract::We studied loss of heterozygosity (LOH) on human chromosome 7q to determine the location of a putative tumor suppressor gene (TSG) in human primary prostate carcinomas. Samples were obtained from 16 primary prostate carcinomas surgically removed from patients at The University of Texas M. D. Anderson Cancer Center. Pa...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Zenklusen JC,Thompson JC,Troncoso P,Kagan J,Conti CJ

    更新日期:1994-12-15 00:00:00

  • Chromosomal fragile site FRA16D and DNA instability in cancer.

    abstract::It has been proposed that common aphidicolin-inducible fragile sites, in general, predispose to specific chromosomal breakage associated with deletion, amplification, and/or translocation in certain forms of cancer. Although this appears to be the case for the fragile site FRA3B and may be the case for FRA7G, it is no...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Mangelsdorf M,Ried K,Woollatt E,Dayan S,Eyre H,Finnis M,Hobson L,Nancarrow J,Venter D,Baker E,Richards RI

    更新日期:2000-03-15 00:00:00

  • Case-control study of borderline ovarian tumors: reproductive history and exposure to exogenous female hormones.

    abstract::Borderline ovarian tumors possess many of the same morphological features as their malignant counterparts, but they do not destructively invade the ovarian stroma, and the women in whom they develop generally have a favorable prognosis. Female residents of three urban counties of western Washington diagnosed with sero...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Harlow BL,Weiss NS,Roth GJ,Chu J,Daling JR

    更新日期:1988-10-15 00:00:00

  • Mitotic Vulnerability in Triple-Negative Breast Cancer Associated with LIN9 Is Targetable with BET Inhibitors.

    abstract::Triple-negative breast cancers (TNBC) are highly aggressive, lack FDA-approved targeted therapies, and frequently recur, making the discovery of novel therapeutic targets for this disease imperative. Our previous analysis of the molecular mechanisms of action of bromodomain and extraterminal protein inhibitors (BETi) ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-17-1571

    authors: Sahni JM,Gayle SS,Webb BM,Weber-Bonk KL,Seachrist DD,Singh S,Sizemore ST,Restrepo NA,Bebek G,Scacheri PC,Varadan V,Summers MK,Keri RA

    更新日期:2017-10-01 00:00:00

  • Alterations of choline phospholipid metabolism in ovarian tumor progression.

    abstract::Recent characterization of abnormal phosphatidylcholine metabolism in tumor cells by nuclear magnetic resonance (NMR) has identified novel fingerprints of tumor progression that are potentially useful as clinical diagnostic indicators. In the present study, we analyzed the concentrations of phosphatidylcholine metabol...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-05-1146

    authors: Iorio E,Mezzanzanica D,Alberti P,Spadaro F,Ramoni C,D'Ascenzo S,Millimaggi D,Pavan A,Dolo V,Canevari S,Podo F

    更新日期:2005-10-15 00:00:00

  • Evidence for altered gene regulation in HeLa cells returned to culture after growing in immunosuppressed rats.

    abstract::HeLa TCRC-1, is a monophenotypic cell line for the production of the carcinoplacental Regan isoenzyme of alkaline phosphatase. It has been previously reported that, when this cell line is grown in immunosuppressed rats, there is an alteration of phenotypic expression in that an isoenzyme that is referred to as oncoamn...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Singer RM

    更新日期:1976-11-01 00:00:00

  • Focused ultrasound delivers targeted immune cells to metastatic brain tumors.

    abstract::Natural killer (NK) cells are cytotoxic lymphocytes involved in innate immunity. NK-92, a human NK cell line, may be targeted to tumor-associated antigens in solid malignancies where it exhibits antitumor efficacy, but its clinical utility for treating brain tumors is limited by an inability to cross the blood-brain b...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-12-2609

    authors: Alkins R,Burgess A,Ganguly M,Francia G,Kerbel R,Wels WS,Hynynen K

    更新日期:2013-03-15 00:00:00